eLifeNeurosciencePeer-reviewed journal article
Antisense, but not sense, repeat expanded RNAs activate PKR/eIF2α-dependent integrated stress response in C9orf72 FTD/ALS
Janani ParameswaraniD, Nancy Zhang, Elke BraemsiD, Kedamawit TilahuniD, Devesh C. PantiD, Keena YiniD, Seneshaw Asress, Kara Heeren, Anwesha BanerjeeiD, Emma Davis, Samantha L. SchwartziD, Graeme L. ConniD, Gary Jonathan BasselliD, Ludo Van Den BoschiD, Jie JiangiD
- Citations
- 25
- FWCI
- 4.23
- Field percentile
- top 5%
Abstract
GGGGCC (G4C2) hexanucleotide repeat expansion in the C9orf72 gene is the most common genetic cause of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). The repeat is bidirectionally transcribed and confers gain of toxicity. However, the underlying toxic species is debated, and it is not clear whether antisense CCCCGG (C4G2) repeat expanded RNAs contribute to disease pathogenesis. Our study shows that C9orf72 (C4G2) antisense repeat expanded RNAs trigger the activation of the PKR/eIF2-dependent integrated stress response independent of dipeptide repeat proteins that are produced through repeat-associated non-AUG initiated translation, leading to global translation inhibition and stress granule formation. Increased phosphorylation of PKR/eIF2 is also observed in the frontal cortex of C9orf72 FTD/ALS patients. Finally, only antisense (C4G2), but not sense (G4C2), repeat expanded RNAs can activate the PKR/eIF2 pathway. These results provide a mechanism by which antisense repeat expanded RNAs elicit neuronal toxicity in FTD/ALS caused by C9orf72 repeat expansions.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Antisense oligonucleotide targeting pathogenic sense repeat RNA in C9ORF72 suppresses production of antisense-dependent dipeptide repeat proteins implicated in ALS/FTD
Yuanzheng Gu, Mark W. Kankel, … Sandra Almeida·bioRxiv·Oct 4, 2024
- Dual-targeting CRISPR-CasRx reduces C9orf72 ALS/FTD sense and antisense repeat RNAs in vitro and in vivo
Liam Kempthorne, Deniz Vaizoglu, … Adrian M. Isaacs·Nature CommunicationsPeer-reviewed·Jan 8, 2025
- A C. elegans model of C9orf72-associated ALS/FTD uncovers a conserved role for eIF2D in RAN translation
Yoshifumi Sonobe, Jihad Aburas, … Paschalis Kratsios·Nature CommunicationsPeer-reviewed·Oct 15, 2021
- Inflammasome mediated neuronal-microglial crosstalk: a therapeutic substrate for the familial C9orf72 variant of the frontotemporal dementia/amyotrophic lateral sclerosis
Kyle J. Trageser, Chad Smith, … Giulio Maria Pasinetti·bioRxiv·Jan 27, 2022
- G2C4 targeting antisense oligonucleotides potently mitigate TDP-43 dysfunction in C9orf72 ALS/FTD human neurons
Jeffrey D. Rothstein, Victoria Baskerville, … Alyssa N. Coyne·bioRxiv·Jun 26, 2023
- Inducible expression of human C9ORF72 36x G4C2 hexanucleotide repeats is sufficient to cause RAN translation and rapid muscular atrophy in mice
Fréderike W. Riemslagh, Esmay C. van der Toorn, … Rob Willemsen·Disease Models & MechanismsPeer-reviewed·Jan 11, 2021